Nova Leap Health Past Earnings Performance
Past criteria checks 0/6
Nova Leap Health's earnings have been declining at an average annual rate of -18.2%, while the Healthcare industry saw earnings growing at 16.2% annually. Revenues have been growing at an average rate of 11.1% per year.
Key information
-18.2%
Earnings growth rate
-14.4%
EPS growth rate
Healthcare Industry Growth | -6.7% |
Revenue growth rate | 11.1% |
Return on equity | -2.5% |
Net Margin | -1.8% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Nova Leap Health Corp.'s (CVE:NLH) 35% Share Price Surge Not Quite Adding Up
Oct 31Risks Still Elevated At These Prices As Nova Leap Health Corp. (CVE:NLH) Shares Dive 27%
Sep 12Nova Leap Health Corp.'s (CVE:NLH) 33% Price Boost Is Out Of Tune With Revenues
Jun 08Should Shareholders Reconsider Nova Leap Health Corp.'s (CVE:NLH) CEO Compensation Package?
May 31Nova Leap Health Corp. (CVE:NLH) Looks Just Right With A 28% Price Jump
Mar 23Market Participants Recognise Nova Leap Health Corp.'s (CVE:NLH) Revenues
Jan 06Nova Leap Health Corp. (CVE:NLH) Investors Are Less Pessimistic Than Expected
Jul 29Does Nova Leap Health (CVE:NLH) Have A Healthy Balance Sheet?
Feb 22Calculating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)
Aug 17Nova Leap Health (CVE:NLH) Is Carrying A Fair Bit Of Debt
May 14Estimating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)
Oct 22Nova Leap Health (CVE:NLH) Strong Profits May Be Masking Some Underlying Issues
Mar 18Revenue & Expenses Breakdown
How Nova Leap Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 26 | 0 | 8 | 0 |
30 Jun 24 | 26 | 0 | 8 | 0 |
31 Mar 24 | 26 | 0 | 8 | 0 |
31 Dec 23 | 26 | -1 | 8 | 0 |
30 Sep 23 | 26 | -1 | 9 | 0 |
30 Jun 23 | 27 | -1 | 9 | 0 |
31 Mar 23 | 27 | -1 | 9 | 0 |
31 Dec 22 | 28 | -1 | 10 | 0 |
30 Sep 22 | 27 | -1 | 9 | 0 |
30 Jun 22 | 25 | 0 | 9 | 0 |
31 Mar 22 | 24 | 0 | 8 | 0 |
31 Dec 21 | 21 | 2 | 8 | 0 |
30 Sep 21 | 20 | 4 | 7 | 0 |
30 Jun 21 | 19 | 3 | 7 | 0 |
31 Mar 21 | 18 | 2 | 6 | 0 |
31 Dec 20 | 17 | 1 | 6 | 0 |
30 Sep 20 | 18 | 0 | 6 | 0 |
30 Jun 20 | 18 | -1 | 5 | 0 |
31 Mar 20 | 18 | 0 | 5 | 0 |
31 Dec 19 | 17 | -1 | 5 | 0 |
30 Sep 19 | 16 | -1 | 5 | 0 |
30 Jun 19 | 15 | -1 | 5 | 0 |
31 Mar 19 | 13 | -1 | 4 | 0 |
31 Dec 18 | 10 | -1 | 4 | 0 |
30 Sep 18 | 7 | -1 | 3 | 0 |
30 Jun 18 | 5 | -1 | 2 | 0 |
31 Mar 18 | 2 | -1 | 2 | 0 |
31 Dec 17 | 1 | -1 | 1 | 0 |
31 Dec 16 | 0 | 0 | 0 | 0 |
31 Oct 16 | 0 | 0 | 0 | 0 |
Quality Earnings: NLH is currently unprofitable.
Growing Profit Margin: NLH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NLH is unprofitable, and losses have increased over the past 5 years at a rate of 18.2% per year.
Accelerating Growth: Unable to compare NLH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NLH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).
Return on Equity
High ROE: NLH has a negative Return on Equity (-2.51%), as it is currently unprofitable.